Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ.

Acta Neuropathol. 2007 Sep;114(3):221-9. Epub 2007 Jul 25.

PMID:
17653732
2.

Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.

Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Kosaka K, Arai H.

Brain Res. 2007 Dec 12;1184:284-94. Epub 2007 Oct 25.

PMID:
17963732
3.

Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.

Kokoulina P, Rohn TT.

Neurodegener Dis. 2010;7(4):243-50. doi: 10.1159/000287952. Epub 2010 May 5.

4.

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Jellinger KA.

Acta Neuropathol. 2003 Sep;106(3):191-201. Epub 2003 Jul 5. Erratum in: Acta Neuropathol (Berl). 2003 Dec;106(6):588.

PMID:
12845452
5.

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H.

Acta Neuropathol. 2009 Feb;117(2):125-36. doi: 10.1007/s00401-008-0480-1. Epub 2009 Jan 13.

PMID:
19139911
6.

Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.

Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.

Brain Res. 1999 Oct 2;843(1-2):53-61.

PMID:
10528110
7.

[Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].

Zhu M, Wang L, Liu J, Gui Q, Guo Y, Hu Y, Zhang H.

Zhonghua Bing Li Xue Za Zhi. 2015 Aug;44(8):587-93. Chinese.

PMID:
26705184
8.

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.

Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J.

Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11.

PMID:
25758940
9.

Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, Xie SX, Kwong LK, Elman L, McCluskey L, Clark CM, Malunda J, Miller BL, Zimmerman EA, Qian J, Van Deerlin V, Grossman M, Lee VM, Trojanowski JQ.

Arch Neurol. 2009 Feb;66(2):180-9. doi: 10.1001/archneurol.2008.558.

10.

Clinical and neuropathological correlates of Lewy body disease.

Hishikawa N, Hashizume Y, Yoshida M, Sobue G.

Acta Neuropathol. 2003 Apr;105(4):341-50. Epub 2003 Jan 14.

PMID:
12624787
11.

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.

Tsuboi Y, Uchikado H, Dickson DW.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S221-4. doi: 10.1016/S1353-8020(08)70005-1.

PMID:
18267239
12.

Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.

Kalaitzakis ME, Pearce RK, Gentleman SM.

Neurosci Lett. 2009 Sep 11;461(1):12-5. doi: 10.1016/j.neulet.2009.05.083. Epub 2009 Jun 10.

PMID:
19523504
13.
14.

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T.

Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11. Epub 2006 Oct 30.

PMID:
17084815
15.

Lewy body-related alpha-synucleinopathy in the aged human brain.

Jellinger KA.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. Epub 2004 Apr 2.

PMID:
15480835
16.

Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M, McCluskey LF, Trojanowski JQ, Lee VM.

Am J Pathol. 2008 Jul;173(1):182-94. doi: 10.2353/ajpath.2008.080003. Epub 2008 Jun 5.

17.

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.

Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K.

Neurosci Lett. 2010 Dec 3;486(1):19-23. doi: 10.1016/j.neulet.2010.09.036. Epub 2010 Sep 17.

PMID:
20851165
19.

Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.

Francis PT.

J Neurol. 2009 Aug;256 Suppl 3:280-5. doi: 10.1007/s00415-009-5247-7. Review.

PMID:
19711117
20.

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.

Galvin JE, Uryu K, Lee VM, Trojanowski JQ.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13450-5.

Supplemental Content

Support Center